Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer
Clinical trial NCT00050141 · COMPLETED
Trial details
- NCT number
- NCT00050141
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-09-01
- Primary completion
- 2005-10-01
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.